에서 실시간으로 운영 중이에요! 자세히 알아보기

NSTG

NanoString Technologies, Inc.

NSTG

시가총액 US$507만

상장 폐지됨

NSTG은(는) 2024년 2월 13일에 상장 폐지됐어요.

순위로 돌아가기

소개: NanoString Technologies Inc is engaged in the development, manufacturing and commercialization of instruments, consumables, and services for efficiently profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. Its core technology includes proprietary chemistries that enable the labeling and counting of single molecules. The firm uses its technology to develop tools for scientific and clinical research, primarily in the fields of genomics and proteomics. It offers two product platforms such as nCounter Analysis System or nCounter, and GeoMx Digital Spatial Profiler or DSP system both include instruments, related consumables, and software. NanoString Technologies generates revenue from the sale of products and related services and collaborations.

직원 수: 703

건강관리 제약 - 종합

뉴스

긍정적

중립

부정적

투자 심리 3개월

긍정적 0%

중립 0%

부정적 0%

Why Is NanoString (NSTG) Stock Up 115% Today?

Life science applications specialist NanoString (NASDAQ: NSTG ), which provides tools for discovery and translation research, announced that it has entered into a credit agreement with its existing lenders. Driving the need for such an arrangement was a bankruptcy filing at the beginning of the week.

NanoString Announces Completion of Financing to Support Restructuring Process

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the Company has entered into a credit agreement with its existing lenders comprised of (a) $12,500,000 in new money term loans which have already been approved for funding pursuant to the February 5 interim order of the U.S. Bankruptcy court approving the credit facility, and (b) an additional $35,000,000 in new money term loa.

NanoString Announces Completion of Financing to Support Restructuring Process

Why Is NanoString (NSTG) Stock Up 180% Today?

Investors looking at today's price action in NanoString (NASDAQ: NSTG ) stock ought to be shaking their heads in amazement. Indeed, after announcing the company would be filing for bankruptcy protection on Monday, many thought the story with NanoString was over.

NanoString stock sinks 70% as Seattle biotech company enters bankruptcy process

Seattle-based publicly traded biotech company NanoString Technologies announced Monday that it has initiated a Chapter 11 bankruptcy plan and is exploring a potential sale in the latest fallout from its loss in a patent infringement case against 10X Genomics.

Why Is NanoString Technologies (NSTG) Stock Down 59% Today?

NanoString Technologies (NASDAQ: NSTG ) stock is taking a beating on Monday after the company announced a voluntary Chapter 11 bankruptcy filing. NanoString Technologies notes that this bankruptcy filing is the result of its lost litigation battles against 10x Genomics.

NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG) (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that steps are being taken to protect its business, customers, employees and its mission to “Map the Universe of Biology.” With support from key creditors, NanoString and certain of its subsidiaries have voluntarily initiated a chapter 11 restructuring proceeding in the United States Bankruptcy.

NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology

NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability

SEATTLE--(BUSINESS WIRE)-- #AGBT2024--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the CosMx™ Human 6K Discovery Panel, the industry's first single-cell spatial panel enabling research scientists to measure over 6,000 RNA targets, representing nearly every human biological pathway. Building on this breakthrough product developed for the CosMx Spatial Molecular Imager (SMI), Nan.

NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability

NanoString's CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of the first public dataset of the whole transcriptome obtained at true single-cell resolution on the CosMx™ Spatial Molecular Imager (SMI). The data will be highlighted at the 42nd annual J.P. Morgan Healthcare Conference 2024 in San Francisco during NanoString's corporate presentation on Wednesday, January 10, 20.

NanoString's CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution

NanoString Technologies to cut 9% of workforce, gets delisting notice from Nasdaq

Seattle-based publicly traded biotech company NanoString Technologies said in a filing Friday that it plans to cut about 50 positions, or 9% of its workforce.

NanoString Reports Inducement Grants Under Nasdaq Listing Rules

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 10 new employees. In accordance with Nasdaq Listing Rule 5635(c)(4), on December 6, 2023, the Compensation and Human Capital Committee of NanoString's Board of Directors approved the grant of, in the aggregate, 34,925 restricted stock units, or RSUs, as mat.

NanoString Reports Inducement Grants Under Nasdaq Listing Rules

뉴스 순위 보기

Lightweight Charts™를 사용해 가격 차트를 구현했어요.